Diligence memo · auto-generated · as of July 2, 2026

OptiMedica Corp

OptiMedica Corp looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

OptiMedica Corp operates in Other Health Care, based in SUNNYVALE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

OptiMedica Corp has raised $90M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $35M on 2012-11-13.

Most recent recorded round closed around 2012-11-13.

Valuation (modeled)modeled

Provath models OptiMedica Corp at approximately $775M (range $82M–$3.0B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.81× the median modeled value of Series B Other Health Care companies in 2010–2012 (50 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 20 months.

Last raise 13.6 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 1.4× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 95% of Other Health Care peers (5377 compared).

Modeled value ranks above 96% of those peers.

Closest niche peers: Cell MDX, LLC, Riverchase Holdings Mso, Llc, CDRT Holding Corp, Pivot Medical Inc, Fresenius Vascular Care San Antonio MSO, LLC.

Peoplefiled

16 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.